BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33232920)

  • 1. Nomogram based on preoperative CT imaging predicts the EGFR mutation status in lung adenocarcinoma.
    Zhang G; Zhang J; Cao Y; Zhao Z; Li S; Deng L; Zhou J
    Transl Oncol; 2021 Jan; 14(1):100954. PubMed ID: 33232920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potential of Radiomics Nomogram in Non-invasively Prediction of Epidermal Growth Factor Receptor Mutation Status and Subtypes in Lung Adenocarcinoma.
    Zhao W; Wu Y; Xu Y; Sun Y; Gao P; Tan M; Ma W; Li C; Jin L; Hua Y; Liu J; Li M
    Front Oncol; 2019; 9():1485. PubMed ID: 31993370
    [No Abstract]   [Full Text] [Related]  

  • 3. A nomogram based on
    Guo Y; Zhu H; Chen C; Li X; Liu F; Yao Z
    Quant Imaging Med Surg; 2022 Nov; 12(11):5239-5250. PubMed ID: 36330175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
    Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y
    Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-energy CT-based radiomics in predicting EGFR mutation status non-invasively in lung adenocarcinoma.
    Ma JW; Jiang X; Wang YM; Jiang JM; Miao L; Qi LL; Zhang JX; Wen X; Li JW; Li M; Zhang L
    Heliyon; 2024 Jan; 10(2):e24372. PubMed ID: 38304841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.
    Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D
    Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of radiomics captured from CT to predict the EGFR mutation status and TKIs therapeutic sensitivity of advanced lung adenocarcinoma].
    Yang CS; Chen WD; Gong GZ; Li ZJ; Qiu QT; Yin Y
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):282-287. PubMed ID: 31014053
    [No Abstract]   [Full Text] [Related]  

  • 8. [Plasma relative abundance of epidermal growth factor receptor mutations predicts clinical response to epidermal growth factor receptor-tyrosine kinase inhibitors in patients with advanced lung adenocarcinoma].
    Xu HY; Lai QQ; Su SS; Zhou LP; Ye JR; Zhang DQ; Xie YP; Li YP
    Zhonghua Nei Ke Za Zhi; 2019 Jan; 58(1):49-55. PubMed ID: 30605951
    [No Abstract]   [Full Text] [Related]  

  • 9. Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I/II lung adenocarcinoma.
    Zou J; Lv T; Zhu S; Lu Z; Shen Q; Xia L; Wu J; Song Y; Liu H
    Thorac Cancer; 2017 May; 8(3):260-270. PubMed ID: 28383802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor-tyrosine kinase inhibitors.
    Chang HC; Chen YM; Tseng CC; Huang KT; Wang CC; Chen YC; Lai CH; Fang WF; Kao HC; Lin MC
    Tumour Biol; 2017 Mar; 39(3):1010428317695939. PubMed ID: 28351317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer.
    Zhang L; Chen B; Liu X; Song J; Fang M; Hu C; Dong D; Li W; Tian J
    Transl Oncol; 2018 Feb; 11(1):94-101. PubMed ID: 29216508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning.
    Wang S; Shi J; Ye Z; Dong D; Yu D; Zhou M; Liu Y; Gevaert O; Wang K; Zhu Y; Zhou H; Liu Z; Tian J
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30635290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT imaging-based histogram features for prediction of EGFR mutation status of bone metastases in patients with primary lung adenocarcinoma.
    Shen TX; Liu L; Li WH; Fu P; Xu K; Jiang YQ; Pan F; Guo Y; Zhang MC
    Cancer Imaging; 2019 Jun; 19(1):34. PubMed ID: 31174617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer.
    Huang YQ; Liang CH; He L; Tian J; Liang CS; Chen X; Ma ZL; Liu ZY
    J Clin Oncol; 2016 Jun; 34(18):2157-64. PubMed ID: 27138577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma.
    Liu Y; Kim J; Qu F; Liu S; Wang H; Balagurunathan Y; Ye Z; Gillies RJ
    Radiology; 2016 Jul; 280(1):271-80. PubMed ID: 26937803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of epidermal growth factor receptor mutations in pulmonary adenocarcinoma using dual-energy spectral computed tomography.
    Li M; Zhang L; Tang W; Jin YJ; Qi LL; Wu N
    Eur Radiol; 2019 Jun; 29(6):2989-2997. PubMed ID: 30367185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep CNN Model Using CT Radiomics Feature Mapping Recognizes EGFR Gene Mutation Status of Lung Adenocarcinoma.
    Zhang B; Qi S; Pan X; Li C; Yao Y; Qian W; Guan Y
    Front Oncol; 2020; 10():598721. PubMed ID: 33643902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.
    Ludovini V; Bianconi F; Pistola L; Chiari R; Minotti V; Colella R; Giuffrida D; Tofanetti FR; Siggillino A; Flacco A; Baldelli E; Iacono D; Mameli MG; Cavaliere A; Crinò L
    J Thorac Oncol; 2011 Apr; 6(4):707-15. PubMed ID: 21258250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations Study Between
    Yang B; Wang QG; Lu M; Ge Y; Zheng YJ; Zhu H; Lu G
    Front Oncol; 2019; 9():589. PubMed ID: 31380265
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival outcome assessed according to tumor burden and progression patterns in patients with epidermal growth factor receptor mutant lung adenocarcinoma undergoing epidermal growth factor receptor tyrosine kinase inhibitor therapy.
    Cha YK; Lee HY; Ahn MJ; Choi YL; Lee JH; Park K; Lee KS
    Clin Lung Cancer; 2015 May; 16(3):228-36. PubMed ID: 25499173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.